Company Filing History:
Years Active: 2025
Title: Gabrielle St-Pierre: Innovator in Macrocyclic Inhibitors
Introduction
Gabrielle St-Pierre is a prominent inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of MCL-1 inhibitors. Her innovative work has the potential to impact cancer treatment and therapeutic strategies.
Latest Patents
Gabrielle holds a patent for the "Ring closing synthesis of macrocyclic MCL-1 inhibitor intermediates." This patent outlines processes for synthesizing MCL-1 inhibitors and intermediates, including compound F, which can be utilized in their preparation. The patent specifically details the synthesis of compound A1 and compound A2, along with their respective salts and solvates.
Career Highlights
Gabrielle is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. Her work at Amgen has allowed her to collaborate with other talented professionals in the field, enhancing her contributions to drug development.
Collaborations
Some of Gabrielle's notable coworkers include Austin G. Smith and Jason S. Tedrow. Their collaborative efforts have fostered a dynamic environment for innovation and research within the company.
Conclusion
Gabrielle St-Pierre's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to the synthesis of MCL-1 inhibitors are paving the way for advancements in cancer treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.